Results 221 to 230 of about 9,870,305 (401)
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John+5 more
wiley +1 more source
Commentary, The Washington Conference on Clinical Pharmacology [PDF]
Edward A. Carr
openalex +1 more source
Leading the Way: Multi-Drug Resistance Protein (MDR1) and Clinical Pharmacology-Commentary on Kim et al. [PDF]
Giacomini KM.
europepmc +1 more source
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li+9 more
wiley +1 more source
Clotrimazole (Bay b 5097): In Vitro and Clinical Pharmacological Studies
M. A. Burgess, Gerald P. Bodey
openalex +1 more source
What goes in the regulatory clinical pharmacology package for an oncolytic virus? [PDF]
Yum SY, Jang K, de Castro FA, Manon A.
europepmc +1 more source
Engineering the Future of Restorative Clinical Peripheral Nerve Surgery
What if damaged nerves could regenerate more effectively? This review unveils cutting‐edge strategies to restore nerve function, from biomaterial scaffolds and bioactive molecules to living engineered tissues. By accelerating axonal regrowth, preserving Schwann cells, and enhancing connectivity, these approaches are reshaping nerve repair—offering new ...
Justin C. Burrell+5 more
wiley +1 more source
Editorial: New GPCR targets and modulators to treat CNS disorders
Philippe De Deurwaerdère+5 more
doaj +1 more source
Clinical pharmacological studies of amoxycillin: effect of probenecid.
Rashmi H. Barbhaiya+3 more
openalex +1 more source
Clinical pharmacology of intravitreal anti-VEGF drugs
S. Fogli+5 more
semanticscholar +1 more source